Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 5, 2011, Pages 1311-1320

  Bahmani, Peyman ^a   Schellenberger, Eyk ^a   Klohs, Jan ^b   Steinbrink, Jens ^a   Cordell, Ryan ^a   Zille, Marietta ^a   Müller, Jochen ^a   Harhausen, Denise ^a   Hofstra, Leo ^c   Reutelingsperger, Chris ^d   Farr, Tracy Deanne ^a   Dirnagl, Ulrich ^a   Wunder, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

annexin A5; cell death; fluorescence imaging; propidium iodide; stroke; TUNEL staining

Indexed keywords

CELL MARKER; DNA; LIPOCORTIN 5; PROPIDIUM IODIDE; BIOLOGICAL MARKER; CARBOCYANINE; CY5.5 CYANINE DYE; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; C57BL 6 MOUSE; CELL DEATH; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE; HEMISPHERE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR IMAGING; MOUSE; NEAR INFRARED SPECTROSCOPY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY; STAINING; STROKE; ANIMAL; C57BL MOUSE; FLUORESCENCE MICROSCOPY; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANNEXIN A5; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CARBOCYANINES; CELL DEATH; FLUORESCENT DYES; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; PROPIDIUM; STAINING AND LABELING;

EID: 79959613087     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.233     Document Type: Article

References (44)

1. Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1-13 (Pubitemid 38569790)
2. Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, Rigo P, Green A (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8:2766-74 (Pubitemid 35025718)
3. Blankenberg FG (2008a) Monitoring of treatment-induced apoptosis in oncology with PETand SPECT. Curr Pharm Des 14:2974-82
4. Blankenberg FG (2008b) In vivo imaging of apoptosis. Cancer Biol Ther 7:1525-32
5. Blankenberg FG, Kalinyak J, Liu L, Koike M, Cheng D, Goris ML, Green A, Vanderheyden JL, Tong DC, Yenari MA (2006) 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody. Eur J Nucl Med Mol Imaging 33:566-74
6. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-7 (Pubitemid 29453643)
7. Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, Hofstra L (2001) Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 7:1352-5 (Pubitemid 34007941)
8. Faust A, Hermann S, Wagner S, Haufe G, Schober O, Schafers M, Kopka K (2009) Molecular imaging of apoptosis in vivo with scintigraphic and optical biomarkers-a status report. Anticancer Agents Med Chem 9:968-85
9. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Jaattela M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nunez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G (2009) Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16:1093-107
10. Greupink R, Sio CF, Ederveen A, Orsel J (2009) Evaluation of a 99mTc-labeled AnnexinA5 variant for non-invasive SPECT imaging of cell death in liver, spleen and prostate. Pharm Res 26:2647-56
11. Hara H, Huang PL, Panahian N, Fishman MC, Moskowitz MA (1996) Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 16:605-11 (Pubitemid 26227069)
12. Harraz MM, Dawson TM, Dawson VL (2008) Advances in neuronal cell death 2007. Stroke 39:286-8 (Pubitemid 351619444)
13. Heckl S (2007) Future contrast agents for molecular imaging in stroke. Curr Med Chem 14:1713-28 (Pubitemid 47163409)
14. Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356:209-12 (Pubitemid 30446976)
15. Johanson CE, Duncan III JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD (2008) Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 5:10
16. Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K (2003) Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med 44:947-52 (Pubitemid 39663407)
17. Kenis H, Zandbergen HR, Hofstra L, Petrov AD, Dumont EA, Blankenberg FD, Haider N, Bitsch N, Gijbels M, Verjans JW, Narula N, Narula J, Reutelingsperger CP (2010) Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine exter-nalization and feasibility of radionuclide imaging. J Nucl Med 51:259-67
18. Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, Narula J (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350:1472-3 (Pubitemid 38420011)
19. Klohs J, Baeva N, Steinbrink J, Bourayou R, Boettcher C, Royl G, Megow D, Dirnagl U, Priller J, Wunder A (2009a) In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J Cereb Blood Flow Metab 29:1284-92
20. Klohs J, Grafe M, Graf K, Steinbrink J, Dietrich T, Stibenz D, Bahmani P, Kronenberg G, Harms C, Endres M, Lindauer U, Greger K, Stelzer EH, Dirnagl U, Wunder A (2008) In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke 39:2845-52
21. Klohs J, Steinbrink J, Bourayou R, Mueller S, Cordell R, Licha K, Schirner M, Dirnagl U, Lindauer U, Wunder A (2009b) Near-infrared fluorescence imaging with fluor-escently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice. J Neurosci Methods 180:126-32
22. Klohs J, Steinbrink J, Nierhaus T, Bourayou R, Lindauer U, Bahmani P, Dirnagl U, Wunder A (2006) Noninvasive near-infrared imaging of fluorochromes within the brain of live mice: an in vivo phantom study. Mol Imaging 5:180-7
23. Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, Hartung D, Steinmetz N, Vanderheyden JL, Vannan MA, Gold HK, Reutelingsperger CP, Hofstra L, Narula J (2003) Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108:3134-9 (Pubitemid 38031804)
24. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3-11
25. Laufer EM, Winkens HM, Corsten MF, Reutelingsperger CP, Narula J, Hofstra L (2009) PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5. Q J Nucl Med Mol Imaging 53:26-34
26. Loo DT, Rillema JR (1998) Measurement of cell death. Methods Cell Biol 57:251-64 (Pubitemid 128787444)
27. Lorberboym M, Blankenberg FG, Sadeh M, Lampl Y (2006) In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res 1103:13-9 (Pubitemid 44080115)
28. Moore A, Donahue CJ, Bauer KD, Mather JP (1998) Simultaneous measurement of cell cycle and apoptotic cell death. Methods Cell Biol 57:265-78 (Pubitemid 128787445)
29. Nabeshima S, Reese TS, Landis DM, Brightman MW (1975) Junctions in the meninges and marginal glia. J Comp Neurol 164:127-69
30. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov Jr A (2003) Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 63:1936-42 (Pubitemid 36460861)
31. Schellenberger EA, Bogdanov Jr A, Hogemann D, Tait J, Weissleder R, Josephson L (2002) Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging 1:102-7
32. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L (2004a) Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15:1062-7 (Pubitemid 39297828)
33. Schellenberger EA, Weissleder R, Josephson L (2004b) Optimal modification of annexin V with fluorescent dyes. Chembiochem 5:271-4 (Pubitemid 39257119)
34. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenz-weig A, Weissleder R, Josephson L (2005) Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 54:718-24 (Pubitemid 41233769)
35. Stratton JR, Dewhurst TA, Kasina S, Reno JM, Cerqueira MD, Baskin DG, Tait JF (1995) Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 92:3113-21
36. Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K, Ritchie JL, Stratton JR (1994) Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res 75:491-501 (Pubitemid 24267333)
37. Tang XN, Wang Q, Koike MA, Cheng D, Goris ML, Blankenberg FG, Yenari MA (2007) Monitoring the protective effects of minocycline treatment with radi-olabeled annexin V in an experimental model of focal cerebral ischemia. J Nucl Med 48:1822-8 (Pubitemid 350099328)
38. Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, Heidendal GA (2003) In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44:391-6 (Pubitemid 39586015)
39. Unal Cevik I, Dalkara T (2003) Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury. Cell Death Differ 10:928-9 (Pubitemid 36939703)
40. Van Tilborg GA, Vucic E, Strijkers GJ, Cormode DP, Mani V, Skajaa T, Reutelingsperger CP, Fayad ZA, Mulder WJ, Nicolay K (2010) Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjug Chem 21:1794-803
41. Wen X, Wu QP, Ke S, Wallace S, Charnsangavej C, Huang P, Liang D, Chow D, Li C (2003) Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninva-sive imaging of tumor apoptosis. Cancer Biother Radio-pharm 18:819-27 (Pubitemid 37377317)
42. Wolters SL, Corsten MF, Reutelingsperger CP, Narula J, Hofstra L (2007) Cardiovascular molecular imaging of apoptosis. Eur J Nucl Med Mol Imaging 34(Suppl 1):S86-98 (Pubitemid 46956023)
43. Yang MY, Chuang H, Chen RF, Yang KD (2002) Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J Leukoc Biol 71:231-7
44. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201